Archived Comments for:
Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients
Revise and correct for AI distributionin in Table 4
Nain-Feng Chu, Shuang-Ho Hospital, Taipei Medical University
21 April 2015
There are some typos in the AI distribution of Table 4.
The AI distribution of AGE less and equal 2.0 and greater than 2.0 subgroups are
AI: 0-4: 44 (50.0%) vs. 5 (7.8%) for male and 49 (46.7%) vs. 21 (16.9%) for female;
AI: 5-8: 37 (42.0%) vs. 39 (60.9%) for male and 47 (44.8%) vs. 67 (54.0%) for female;
AI: 9-12: 7 (8.0%) vs. 20 (31.3%) for male and 9 (8.5%) vs. 36 (29.1%) for female.
Revise and correct for AI distributionin in Table 4
21 April 2015
There are some typos in the AI distribution of Table 4.
The AI distribution of AGE less and equal 2.0 and greater than 2.0 subgroups are
AI: 0-4: 44 (50.0%) vs. 5 (7.8%) for male and 49 (46.7%) vs. 21 (16.9%) for female;
AI: 5-8: 37 (42.0%) vs. 39 (60.9%) for male and 47 (44.8%) vs. 67 (54.0%) for female;
AI: 9-12: 7 (8.0%) vs. 20 (31.3%) for male and 9 (8.5%) vs. 36 (29.1%) for female.
Competing interests
non-competing interests